Member Info for Mekas

Its tricky - its never fun selling at a loss and its hard to predict the future - sometimes would have lost it all, sometimes I would have made it back.

Didn't have a massive holding here when I bought back in (I sold after the consolidation), My average was 60p, I bought more in the slump and now my average is 38p - Considered pulling out at breakeven, but this company makes money and is growing, so rightly or wrongly i'm staying in to see what happens, although its very much bottom drawer at the moment.

I guess the answer possibly lies in your capital allocation, i've taken big positions and still do but its risky and I think i've done poorly overall. Its not wise to have too much in any one company as anything can happen, as i've learnt the hard way.

This feels like a value trap. It doesn't matter if we sell assets for NAV, if we are reinvesting that in just buying more shares, the NAV will only go down.

The gap between NAV and share price is steadily closing, but the wrong way - 10p off NAV in a year.

They surely need a plan to address this? I don't see one forthcoming. Seems like they are happy to sit there and take a cut while not having a plan to grow the NAV at all.

Wasn’t expecting it to be massive, but not that small either

When it dropped .95 initially, I thought maybe should have sold and bought back, but glad I didn’t. Hopefully means the upcoming presentation will be positive

Well if people like what they heard at capital markets day there might be some buying. I’m hopeful they can upload some of the other meetings, as agree with the other poster, the bit that was online was a waste of time. Thankfully had it on in the background while working, because it was just a basic intro only of value to new investors. Last time the share price got here I dumped some to buy back at sub 45p. Don’t feel as confident of it dropping back sub 50p so not doing it this time, and if it goes sub 45p again I’ll consider adding more like I did last week.

When they sold their holdings they had a cash nav of about .60. If they are confidently raising at .75 that bodes well.

Will wait this out some more, already been waiting for years !

I’ve dumped. I was considering dumping this morning, which makes it worse. Maybe I should have rode it out but it’s like an abusive relationship. Good luck to those sticking it out, but I can’t take the risk.

Would be good to know, it’s a pretty big stake after today’s announcement. Funnily enough I bought a small holding here recently due to having a larger holding in SUN

Just watching the last presentation from Newmark. If things go well there could be quite profitable.

I just took a little punt here this week as couldn't really justify buying more SUN lol.

Would not be a fan at all of enforced black box insurance.

However, if the technology was also able to record the details of accidents, it could assist with insurance incidents and proving who is at fault.

I think they mean less cash to pay out on fewer shares in circulation.

Some sense to doing that, if you can get NAV or NAV+ value for assets, would seem sensible to take that and reduce debt.

Could they not have waited to till next week to announce further buyback? Like announce after i've bought more shares with the dividend, lol

What hurts my head is that I really should sell some shares in this after the rise, but I can't bring myself to, as feel its still got further to go

Without the buybacks, you would think the share price might dip further in the short run. Clearly should have sold before ex dividend and bought back, instead of adding. Nevermind, longer term am still bullish on recovery, I don’t feel they can go too much lower unless something terrible happens as the return becomes more attractive. We’ve already downgraded forecasts so hopefully things will improve.

I did enjoy reading the utter optimism of Thalassa (who took their stake last year) - From their RNS at the time:

THAL has recently taken a 15.8% stake in SUN. In the early 90’s I was the first Wall Street banker to visit Conmed (CNMD US), at the time it had a market cap. of ~$30m, today its mkt cap. is $2.3bn. The Medical Device Market (including Laparoscopy) is dominated by Medtronic plc $31.6bn revenues, Abbott Labs $31.3bn revenues, Dasher Corp $29.6bn, John & Johnson $27.4bn, as well as Siemens, Fresenius Medline, Becton Dickinson, GE Healthcare, Stryker, Philips NV, Cardinal Health, Baxter Intl., Boston Scientific all with annual revenues in excess of $10bn.

Bit late on the end of year update, hope that’s not for any bad reasons. This company needs a decent rising profit to get back to where it was share price wise.

I can imagine a modest increase for the next dividend, which should push the share price back up into the 130s at least.

Because Rgo are shifting away from being an investment company. As a long suffering Rgo holder, I’m glad he got a good return.

Probably at the same time they announce the dividend. So going by previous years timing, sometime next week.

I’d like to think they have a good plan for it, I wasn’t expecting it either.